betmiga
astellas pharma europe b.v. - mirabegron - urinary bladder, overactive - urologicals - symptomatic treatment of urgency.increased micturition frequency and / or urgency incontinence as may occur in adult patients with overactive-bladder syndrome.
difene 50 milligram capsules gastro-resistant
astellas pharma co. ltd - diclofenac sodium - capsules gastro-resistant - 50 milligram - acetic acid derivatives and related substances
difene 25 milligram capsules gastro-resistant
astellas pharma co. ltd - diclofenac sodium - capsules gastro-resistant - 25 milligram - acetic acid derivatives and related substances
difene 100 milligram suppositories
astellas pharma co. ltd - diclofenac sodium - suppositories - 100 milligram - acetic acid derivatives and related substances
difene 100 milligram capsules modified release
astellas pharma co. ltd - diclofenac sodium - capsules modified release - 100 milligram - acetic acid derivatives and related substances
difene ampoules 75/3 mg/ml solution injection or concentrate for solution infusion
astellas pharma co. ltd - diclofenac sodium - solution injection or concentrate for solution infusion - 75/3 mg/ml
difene dual release 75 milligram capsules modified release
astellas pharma co. ltd - diclofenac sodium - capsules modified release - 75 milligram - acetic acid derivatives and related substances
nivadil 8 milligram prolonged release capsules
astellas pharma co. ltd - nilvadipine - prolonged release capsules - 8 milligram
nivadil 16 milligram prolonged release capsules
astellas pharma co. ltd - nilvadipine - prolonged release capsules - 16 milligram
omnexel®, 400 micrograms prolonged release tablets, film-coated
astellas pharma co. limited - tamsulosin hydrochloride - prolonged-release tablet - 400 microgram(s) - alpha-adrenoreceptor antagonists; tamsulosin